Snowball logo
logo
AMLX_logo

Amylyx Pharmaceuticals Inc. Common Stock

AMLX β€’ NASDAQ
$32.39-$0.02Β  (0.06%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
0.28522.23380.887.37--
COGS
0.0522.99325.4442.160.525-
Gross Profit
0.28519.24355.345.22(0.525)-
Operating Expenses & Income
Operating Income
(82.69)(201.3)38.8(314.7)(153.3)(162.1)
Total Operating Expenses
82.69220.6316.5359.9152.8142.1
R&D Expenses
44.0493.45128.2104.190.492.34
Selling General & Admin Expenses
38.93127.1178.9111.662.8969.66
Earnings from Continuing Operations
Interest Expense
(0.036)(4.291)----
Interest Income
0.0364.29116.1613.819.30210
Income Tax Expense
(0.052)0.7745.026(0.393)0.0460.046
Net Income
Net Income
(87.88)(198.4)49.27(301.7)(144.7)(152.1)
Supplemental
EBIT
(82.69)(201.3)54.3(291.9)(144.7)(150.2)
EBITDA
(82.64)(200.9)55.38(291)(144.2)(149.8)
In millions of USD, except % and values per 1 share